Facing Addiction in America: Spotlight on Opioids (2 credit hours)

Program Summary:  This course takes a comprehensive and practical look at opioid misuse, treatment, overdose, and recovery.  The course includes a discussion of the prevalence of opioid misuse and the neurobiology of addiction.  Treatment approaches include a combination of medication-assisted treatment and psychosocial therapies.  FDA-approved OUD medications are discussed.  The reading includes Facing Addiction in America:  The Surgeon General’s Spotlight on Opioids.  

This course is recommended for social workers, counselors, and therapists and is appropriate for beginning and intermediate levels of practice.

“Book  Open the Course Reading Here.

Course reading:  Facing Addiction in America:  The Surgeon General’s Spotlight on Opioids

Publisher:  US Department of Health and Human Services; The Office of the Surgeon General

Course Objectives:  To enhance professional practice, values, skills, and knowledge by identifying key issues related to OUD intervention and treatment.

Learning Objectives:  Define prescription opioid misuse and opioid use disorder.  Describe the 3 stages of the addiction cycle and the brain regions associated with them.  Describe the “gold standard” for treating opioid addiction.  Compare the FDA-approved medications for OUD treatment.

Review our pre-reading study guide.

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

1: Fentanyl is considerably __________ potent that heroin.
 
 
2: Opioid overdose deaths were five times higher in 2016 than in 1999.  The majority of these opioid overdose deaths were
 
 
3: Despite the fact that effective treatments for opioid use disorder do exist, only about one in ___________ people with this disorder received specialty treatment for illicit drug use in the past year.
 
 
 
 
4: The primary care system has been slow to implement
 
 
 
 
5: Individuals receiving buprenorphine with counseling have  significantly _______________ total health care costs than individuals receiving little or no treatment for their opioid use disorder.
 
 
6: Which medication can be prescribed by any licensed clinician who has prescribing authority?
 
 
 
7: Brain changes endure long after an individual stops using substances and may produce continued, periodic cravings for the substance that can lead to relapse for many
 
 
 
 
8: Well-supported evidence suggests that the addiction process involves a three-stage cycle:  1) binge/intoxication; 2) withdrawal/negative affect; and 3)
 
 
 
 
9: Which brain region is involved in the stage:  preoccupation/anticipation?
 
 
 
10: Which of the following types of intervention is aimed at all members of a given population?
 
 
 
11: The US Preventive Services Task Force recommends that clinicians screen adults aged 18 years or older for
 
 
 
 
12: The diagnosis of a substance use disorder is made by a trained professional based on _______________ symptoms defined in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
 
 
 
 
13: Naloxone is an opioid antagonist medication approved by the FDA to reverse opioid
 
 
 
 
14: A person with opioid use disorder who undergoes medical withdrawal and returns to use is at a(n)  _________ risk of overdose.
 
 
15: Which FDA approved medication for OUD can only be dispensed in a federally-regulated opioid treatment program?
 
 
 
16: Patients who receive MAT for _____________ than 90 days have not shown improved outcomes.
 
 
17: Decades of research have shown that
 
 
 
18: Which of the following best describes recovery from substance use disorders?
 
 
 
 

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

 

Free State Social Work, LLC, provider #1235, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Free State Social Work, LLC maintains responsibility for this course. ACE provider approval period: 9/6/2021 - 9/6/2024. Social workers completing this course receive 2 clinical continuing education credits.

Free State Social Work has been approved by NBCC as an Approved Continuing Education Provider, ACEP NO. 6605. Programs that do not qualify for NBCC credit are clearly identified. Free State Social Work is solely responsible for all aspects of the programs.

Facing Addiction in America: Spotlight on Opioids, Course #3412, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by Free State Social Work as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 12/21/2020 - 12/21/2022. Social workers completing this course receive 2 Clinical Practice continuing education credits.

G.M. Rydberg-Cox, MSW, LSCSW is the Continuing Education Director at Free State Social Work and responsible for the development of this course.  She received her Masters of Social Work in 1996 from the Jane Addams School of Social Work at the University of Illinois-Chicago and she has over 20 years of experience.  She has lived and worked as a social worker in Chicago, Boston, and Kansas City.  She currently practices in the area of hospital/medical social work.  The reading materials for this course were developed by another organization.

Course Created: August 10, 2019
Filed under: Addiction, Clinical, Healthcare, Opioids